Efficacy of Leuconostoc Mesenteroides

Wonju Severance Christian Hospital

Status: Completed

Conditions: Alcohol Drinking Related Problems; Alcohol Drinking

Treatments: Dietary Supplement: Leuconostoc mesenteroides

Study type: Interventional

Funder types: Other

Identifiers

NCT07017088

EMB-2024-04

Details and patient eligibility

About

Excessive alcohol intake can cause dehydration, digestive issues, oxidative stress, and hangover symptoms like headache and fatigue. Toxic metabolites like acetaldehyde and ROS contribute to liver damage. Chronic drinking activates harmful pathways like MEOS and increases inflammation. Gut-liver axis disruption also worsens hangovers. Probiotics, such as Leuconostoc mesenteroides, may help restore gut health and reduce toxicity, but more clinical research is needed.

Enrollment: 28 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion

• Healthy adults aged between 30 and 60 years
• Body Mass Index (BMI) between 18.5 and 30 kg/m²
• Individuals with a history of hangover experience
• Adults with normal results in blood tests and vital signs
• No organic gastrointestinal disease found in endoscopy within the past 3 months
• Able to consume one bottle of soju within 30 minutes
• Individuals who have personally signed the informed consent form

Exclusion

• Individuals who have consumed excessive alcohol within the past week
• Individuals who participated in a human clinical trial within the past month
• Individuals taking supplements or medications that may affect alcohol metabolism
• Individuals with alcohol metabolism disorders, diabetes, hypertension, gallstones, pancreatitis, gout, active tuberculosis, gastrointestinal bleeding or surgery, or those with kidney, liver (e.g., hepatitis B/C carriers, alcoholic liver disease), heart, lung, gastrointestinal, or neurological diseases
• Pregnant women or those planning to become pregnant
• Individuals who have taken liver function supplements or similar medications/health products within one month before the study
• Individuals who consumed excessive alcohol within one week prior to study participation
• Any other individuals deemed unsuitable for the study by the principal investigator

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

28 participants in 1 patient group

Single arm

Experimental group

Description:

Single group Treatment

Treatment:

Dietary Supplement: Leuconostoc mesenteroides